+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Veterinary Renal Disease Market Size, Share & Trends Analysis Report by Type, Animal Type (Canine, Feline, Bovine, Equine, Others), Route of Administration, Indication, Distribution Channel, Region, and Segment Forecasts, 2024-2030

  • PDF Icon

    Report

  • 154 Pages
  • January 2024
  • Region: Global
  • Grand View Research
  • ID: 5936557
Description Jump to:
The global veterinary renal disease market is anticipated to reach USD 22.90 billion by 2030 and it is projected to grow at a CAGR of 5.49% from 2024 to 2030. Rising prevalence of renal diseases coupled with adoption of therapeutic food as a treatment are key growth drivers for this market. Renal diseases like chronic kidney disease (CKD), renal failure, etc. cause irreversible damage to the renal system of animals. Despite no definite cure for this disease, proper management by various types of therapies can help in the betterment of animal life. One of the most prominent methods is that of nutritional management through therapeutic food.

Another crucial market propeller is the rising adoption of AI in veterinary renal disease diagnostics and treatment. Imaging plays a significant role in veterinary medicine by offering vital data for regular preventative measures as well as the assessment of disease and injury. AI can prove to be a very beneficial tool, especially in radiologist deficient geographies. Associated benefits such as faster and enhanced diagnostic capabilities is anticipated to increase adoption of AI and thereby influence positively on market in near future.

Mars Inc, which is a prominent player in the animal health space, has already stepped into the field of applying AI to veterinary diagnostics and treatment. Antech Diagnostics (Mars Inc.) introduced RenalTech, a cutting-edge diagnostic tool, in 2019. RenalTech uses artificial intelligence (AI) to evaluate pet medical record data and forecast a cat's risk of developing chronic kidney disease (CKD) up to two years ahead of an established clinical diagnosis.

Moreover, market dynamics such as product portfolio expansion, M&A, consolidation activities are further anticipated to provide growth platform to this market. For example, in September 2023, Elanco Animal Health received conditional U.S. FDA approval for Varenzin-CA1 (molidustat oral suspension), as the treatment to control non-regenerative anemia in cats with chronic kidney disease (CKD). Furthermore, in December 2023, Neogen Corporation partnered with the TerraNova Equestrian Center in Myakka City, Florida, making the company the official biosecurity provider of the facility for diagnostic testing products.

Veterinary Renal Disease Market Report Highlights

  • Based on type, the treatment segment led the market with the largest revenue share of 68.99% in 2023, due to the wide array of treatments available coupled with ever growing population of pets globally
  • Based on animal type, the feline segment is expected to grow at the fastest CAGR over the forecast period
  • Based on route of administration, the oral segment held the largest revenue share in 2023 and the injectable segment is expected to have the fastest CAGR over the forecast period
  • Based on the indication, the renal cystitis segment held the largest revenue share of 29.74% in 2023 and nephritis segment is expected to have the second fastest CAGR over the forecast period
  • Rising prevalence of a variety of renal complications in animals, prominent usage of pet food, growing disease awareness initiatives are contributing to the market growth
  • North America accounted for the largest revenue share of the market in 2023. The increasing significance of animal health care in general throughout the region has been identified as a key factor propelling market expansion. The American Pet Products Association estimates that 65.1 million homes in the country have pets in 2023-2024. Moreover, growing pet owners' awareness of animal health and the significance of providing care for animals with renal disorders are fueling the market expansion in North America
  • In May 2023, Dechra Pharmaceuticals announced distribution rights of two products to support kidney health in senior cats - Porus One, and Add One. Porus One contains renaltec, a selective absorber that soaks up precursors of uremia toxins in the cat’s intestines that would ordinarily be removed or regulated by healthy kidneys. Add One is a moist cat treat designed for senior cats, developed to encourage them to eat Porus One, and is said to be useful for cats that prefer dry food


This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1 Methodology and Scope
1.1 Market Segmentation and Scope
1.1.1 Regional Scope
1.1.2 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database:
1.3.2 Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.4 Information/Data Analysis
1.4.1 Information Analysis
1.5 Market Formulation & Visualization
1.6 Data Validation & Publishing
1.7 Model Details
1.7.1 Approach 1: Commodity Flow Analysis
1.7.1.1 Hybrid Market Estimation Model
1.7.2 Approach 2: Volume-Price Analysis (Bottom-Up)
1.7.3 Approach 3: Ancillary Market Analysis
1.7.4 Global Market: Cagr Calculation
1.8 List Of Secondary Sources
Chapter 2 Executive Summary
2.1 Market Snapshot
2.2 Segment Snapshot
2.3 Segment Snapshot
2.4 Competitive Landscape Snapshot
Chapter 3 Veterinary Renal Diseases Market Variables, Trends, & Scope
3.1 Market Lineage Outlook
3.1.1 Parent Market Analysis
3.1.2 Ancillary Market Analysis
3.2 Regulatory Framework
3.2.1 North America
3.2.2 Europe
3.2.3 Asia-Pacific
3.2.4 Latin America
3.2.5 Mea
3.3 Estimated Pet Population By Key Species & Key Countries (2018-2023)
3.4 U.S. Pet Owner Demographics, 2022 & 2023, by Generation
3.5 Prevalence Of Pet Renal Diseases
3.6 Product Price Analysis
3.7 Consumer Preference Analysis
3.8 Veterinary Renal Diseases Market Dynamics
3.8.1 Market Driver Impact Analysis
3.8.1.1 Rising Prevalence Of A Variety Of Renal Complications In Animals
3.8.1.2 Prominent Usage Of Pet Food
3.8.1.3 Growing Disease Awareness Initiatives
3.8.2 Market Restraint Analysis
3.8.2.1 Off-Label Use Of Drugs In Veterinary Treatment
3.8.2.2 Lack Of Structured Regulations And Quality Control
3.9 Veterinary Renal Diseases Market: Porter’s 5 Forces Analysis
3.9.1 Threat Of New Entrants: Moderate
3.9.2 Threat Of Substitutes: Low To Moderate
3.9.3 Bargaining Power Of Buyers: Moderate To High
3.9.4 Bargaining Power Of Suppliers: Low
3.9.5 Competitive Rivalry: High
3.10 Veterinary Renal Diseases Market: Pestel Analysis
3.10.1 Political & Legal
3.10.2 Economic
3.10.3 Social
3.10.4 Technological
3.10.5 Environmental
3.11 Covid-19 Impact Analysis
3.11.1 Pre & Current Impact And Future Scenario
3.11.2 Impact Of Covid-19 On Market Players
Chapter 4 Type Estimates & Trend Analysis, 2018-2030 (USD Million)
4.1 Veterinary Renal Diseases Market By Type: Key Takeaways
4.2 Type Movement Analysis & Market Share, 2023 & 2030
4.3 Veterinary Renal Diseases Market Estimates & Forecast, by Type (USD Million)
4.4 Diagnosis
4.4.1 Diagnosis Market Estimates And Forecasts, 2018-2030 (USD Million)
4.4.1.1 Test Kits & Consumables
4.4.1.1.1 Test Kits & Consumables Market Estimates And Forecasts, 2018-2030 (USD Million)
4.4.1.2 Instruments
4.4.1.2.1 Instruments Market Estimates And Forecasts, 2018-2030 (USD Million)
4.5 Treatment
4.5.1 Treatment Market Estimates And Forecasts, 2018-2030 (USD Million)
4.5.1.1 Drugs
4.5.1.1.1 Drugs Market Estimates And Forecasts, 2018-2030 (USD Million)
4.5.1.1.1.2 Nsaids
4.5.1.1.1.2.1 Nsaids Market Estimates And Forecasts, 2018-2030 (USD Million)
4.5.1.1.1.3 Antibiotics
4.5.1.1.1.3.1 Antibiotics Market Estimates And Forecasts, 2018-2030 (USD Million)
4.5.1.1.1.4 Cystine-Binding Agents
4.5.1.1.1.4.1 Cystine Binding Agents Market Estimates And Forecasts, 2018-2030 (USD Million)
4.5.1.1.1.5 Diuretics
4.5.1.1.1.5.1 Diuretics Market Estimates And Forecasts, 2018-2030 (USD Million)
4.5.1.1.1.6.1 Others Market Estimates And Forecasts, 2018-2030 (USD Million)
4.5.1.2 Therapeutic Food Supplements
4.5.1.2.1 Therapeutic Food Supplements Market Estimates And Forecasts, 2018-2030 (USD Million)
4.5.1.3 Ringer Lactate Solution
4.5.1.3.1 Ringer Lacate Solution Market Estimates And Forecasts, 2018-2030 (USD Million)
Chapter 5 Animal Type Estimates & Trend Analysis, 2018-2030 (USD Million)
5.1 Veterinary Renal Diseases Market By Animal Type: Key Takeaways
5.2 Animal Type Movement Analysis & Market Share, 2023 & 2030
5.3 Veterinary Renal Diseases Market Estimates & Forecast, by Animal Type (USD Million)
5.4 Canine
5.4.1 Canine Market Estimates And Forecasts, 2018-2030 (USD Million)
5.5 Feline
5.5.1 Feline Market Estimates And Forecasts, 2018-2030 (USD Million)
5.6 Bovine
5.6.1 Bovine Market Estimates And Forecasts, 2018-2030 (USD Million)
5.7 Equine
5.7.1 Equine Market Estimates And Forecasts, 2018-2030 (USD Million)
5.8 Others
5.8.1 Others Market Estimates And Forecasts, 2018-2030 (USD Million)
Chapter 6 Route Of Administration Estimates & Trend Analysis, 2018-2030 (USD Million)
6.1 Veterinary Renal Diseases Market By Indication: Key Takeaways
6.2. Route Of Administration Movement Analysis & Market Share, 2023 & 2030
6.3 Veterinary Renal Diseases Market Estimates & Forecast, by Route Of Administration (USD Million)
6.4 Oral
6.4.1 Oral Market Estimates And Forecasts, 2018-2030 (USD Million)
6.5 Injectable
6.5.1 Injectable Market Estimates And Forecasts, 2018-2030 (USD Million)
Chapter 7 Indication Estimates & Trend Analysis, 2018-2030 (USD Million)
7.1 Veterinary Renal Diseases Market By Indication: Key Takeaways
7.2. Indication Movement Analysis & Market Share, 2023 & 2030
7.3. Veterinary Renal Diseases Market Estimates & Forecast, by Indication (USD Million)
7.4. Renal Failure
7.4.1 Renal Failure Market Estimates And Forecasts, 2018-2030 (USD Million)
7.5 Chronic Kidney Diseases (Ckd)
7.5.1 Chronic Kidney Diseases (Ckd) Market Estimates And Forecasts, 2018-2030 (USD Million)
7.6 Renal Cystitis
7.6.1 Renal Cystitis Market Estimates And Forecasts, 2018-2030 (USD Million)
7.7 Kidney Stones
7.7.1 Kidney Stones Market Estimates And Forecasts, 2018-2030 (USD Million)
7.8 Nephritis
7.8.1 Nephritis Market Estimates And Forecasts, 2018-2030 (USD Million)
7.9 Others
7.9.1 Others Market Estimates And Forecasts, 2018-2030 (USD Million)
Chapter 8 Distribution Channel Estimates & Trend Analysis, 2018-2030 (USD Million)
8.1 Veterinary Renal Diseases Market By Distribution Channel: Key Takeaways
8.2 Distribution Channel Movement Analysis & Market Share, 2023 & 2030
8.3 Veterinary Renal Diseases Market Estimates & Forecast, by Distribution Channel (USD Million)
8.4 Veterinary Hospitals & Clinics
8.4.1 Veterinary Hospitals & Clinics Market Estimates And Forecasts, 2018-2030 (USD Million)
8.5 Pet Specialty Stores
8.5.1 Pet Specialty Stores Market Estimates And Forecasts, 2018-2030 (USD Million)
8.6 E-Commerce
8.6.1 E-Commerce Market Estimates And Forecasts, 2018-2030 (USD Million)
8.7 Others
8.7.1 Others Market Estimates And Forecasts, 2018-2030 (USD Million)
Chapter 9 Regional Estimates & Trend Analysis, 2018-2030 (USD Million)
9.1 Regional Outlook
9.2 Regional Market Share Analysis, 2023 & 2030
9.3 Regional Marketplace, Key Takeaways
9.4 Regional Marketplace, Key Takeaways
9.5 North America
9.5.1 Swot Analysis:
9.5.2 North America Veterinary Renal Diseases Market Estimates And Forecasts, 2018-2030 (USD Million)
9.5.3 U.S.
9.5.3.1 Key Country Dynamics
9.5.3.2 U.S. Veterinary Renal Diseases Market Estimates And Forecasts, 2018-2030 (USD Million)
9.5.4 Canada
9.5.4.1 Key Country Dynamics
9.5.4.2 Canada Veterinary Renal Diseases Market Estimates And Forecasts, 2018-2030 (USD Million)
9.6 Europe
9.6.1 Swot Analysis:
9.6.2 Europe Veterinary Renal Diseases Market Estimates And Forecasts, 2018-2030 (USD Million)
9.6.3 Germany
9.6.3.1 Key Country Dynamics
9.6.3.2 Germany Veterinary Renal Diseases Market Estimates And Forecasts, 2018-2030 (USD Million)
9.6.4 Uk
9.6.4.1 Key Country Dynamics
9.6.4.2 Uk Veterinary Renal Diseases Market Estimates And Forecasts, 2018-2030 (USD Million)
9.6.5 France
9.6.5.1 Key Country Dynamics
9.6.5.2 France Veterinary Renal Diseases Market Estimates And Forecasts, 2018-2030 (USD Million)
9.6.6 Spain
9.6.6.1 Key Country Dynamics
9.6.6.2 Spain Veterinary Renal Diseases Market Estimates And Forecasts, 2018-2030 (USD Million)
9.6.7 Italy
9.6.7.1 Key Country Dynamics
9.6.7.2 Italy Veterinary Renal Diseases Market Estimates And Forecasts, 2018-2030 (USD Million)
9.6.8 Denmark
9.6.8.1 Key Country Dynamics
9.6.8.2 Denmark Veterinary Renal Diseases Market Estimates And Forecasts, 2018-2030 (USD Million)
9.6.9 Norway
9.6.9.1 Key Country Dynamics
9.6.9.2 Norway Veterinary Renal Diseases Market Estimates And Forecasts, 2018-2030 (USD Million)
9.6.9 Sweden
9.6.9.1 Key Country Dynamics
9.6.9.2 Sweden Veterinary Renal Diseases Market Estimates And Forecasts, 2018-2030 (USD Million)
9.7 Asia-Pacific
9.7.1 Swot Analysis
9.7.2 Asia-Pacific Veterinary Renal Diseases Market Estimates And Forecasts, 2018-2030 (USD Million)
9.7.3 Japan
9.7.3.1 Key Country Dynamics
9.7.3.2 Japan Veterinary Renal Diseases Market Estimates And Forecasts, 2018-2030 (USD Million)
9.7.4 China
9.7.4.1 Key Country Dynamics
9.7.4.2 China Veterinary Renal Diseases Market Estimates And Forecasts, 2018-2030 (USD Million)
9.7.5 India
9.7.5.1 Key Country Dynamics
9.7.5.2 India Veterinary Renal Diseases Market Estimates And Forecasts, 2018-2030 (USD Million)
9.7.6 Australia
9.7.6.1 Key Country Dynamics
9.7.6.2 Australia Veterinary Renal Diseases Market Estimates And Forecasts, 2018-2030 (USD Million)
9.7.7 South Korea
9.7.7.1 Key Country Dynamics
9.7.7.2 South Korea Veterinary Renal Diseases Market Estimates And Forecasts, 2018-2030 (USD Million)
9.7.8 Thailand
9.7.8.1 Key Country Dynamics
9.7.8.2 Thailand Veterinary Renal Diseases Market Estimates And Forecasts, 2018-2030 (USD Million)
9.8 Latin America
9.8.1 Latin America Swot Analysis
9.8.2 Latin America Veterinary Renal Diseases Market Estimates And Forecasts, 2018-2030 (USD Million)
9.8.3 Brazil
9.8.3.1 Key Country Dynamics
9.8.3.2 Brazil Veterinary Renal Diseases Market Estimates And Forecasts, 2018-2030 (USD Million)
9.8.4 Mexico
9.8.4.1 Mexico Veterinary Renal Diseases Market Estimates And Forecasts, 2018-2030 (USD Million)
9.8.5 Argentina
9.8.5.1 Argentina Veterinary Renal Diseases Market Estimates And Forecasts, 2018-2030 (USD Million)
9.9 MEA
9.9.1 MEA SWOT ANALYSIS
9.9.2 MEA Veterinary Renal Diseases Market Estimates And Forecasts, 2018-2030 (USD Million)
9.9.3 South Africa
9.9.3.1 Key Country Dynamics
9.9.3.2 South Africa Veterinary Renal Diseases Market Estimates And Forecasts, 2018-2030 (USD Million)
9.9.4 Saudi Arabia
9.9.4.1 Saudi Arabia Veterinary Renal Diseases Market Estimates And Forecasts, 2018-2030 (USD Million)
9.9.5 Kuwait
9.9.5.1 Kuwait Veterinary Renal Diseases Market Estimates And Forecasts, 2018-2030 (USD Million)
9.9.6 UAE
Chapter 10 Competitive Landscape
10.1 Participants’ Overview
10.2 Financial Performance
10.3 Service Benchmarking
10.4 Market Participant Categorization
10.5 Estimated Market Position Analysis, 2022 (Heat Map Analysis)
10.6 Strategy Mapping
10.6.1 EXPANSION
10.6.2 MERGERS & ACQUISITIONS
10.6.3 PARTNERSHIPS & COLLABORATIONS
10.6.4 SERVICE LAUNCHES/ EXPANSIONS
10.6.5 OTHERS
10.7 Company Profiles
10.7.1. Mars inc.
10.7.1.1. Participant’s overview
10.7.1.2. Financial performance
10.7.1.3. Product benchmarking
10.7.1.4. Strategic initiatives
10.7.2. Nestle Purina Petcare
10.7.2.1. Participant’s overview
10.7.2.2. Financial performance
10.7.2.3. Product benchmarking
10.7.2.4. Strategic initiatives
10.7.3. Hills Pet Nutrition.
10.7.3.1. Participant’s overview
10.7.3.2. Financial performance
10.7.3.3. Product benchmarking
10.7.3.4. Strategic initiatives
10.7.4. J M Smucker.
10.7.4.1. Participant’s overview
10.7.4.2. Financial performance
10.7.4.3. Product benchmarking
10.7.4.4. Strategic initiatives
10.7.5. General Mills
10.7.5.1. Participant’s overview
10.7.5.2. Financial performance
10.7.5.3. Product benchmarking
10.7.5.4. Strategic initiatives
10.7.6. Zoetis Inc.
10.7.6.1. Participant’s overview
10.7.6.2. Financial performance
10.7.6.3. Product benchmarking
10.7.6.4. Strategic initiatives
10.7.7. Merck & Co. Inc.
10.7.7.1. Participant’s overview
10.7.7.2. Financial performance
10.7.7.3. Product benchmarking
10.7.7.4. Strategic initiatives
10.7.8. Elanco.
10.7.8.1. Participant’s overview
10.7.8.2. Financial performance
10.7.8.3. Product benchmarking
10.7.8.4. Strategic initiatives
10.7.9. Phibro Animal Health Corporation.
10.7.9.1. Participant’s overview
10.7.9.2. Financial performance
10.7.9.3. Product benchmarking
10.7.9.4. Strategic initiatives
10.7.10. Ceva Sante Animale
10.7.10.1. Participant’s overview
10.7.10.2. Financial performance
10.7.10.3. Product benchmarking
10.7.10.4. Strategic initiatives
10.7.11. Boehringer Ingelheim Animal Health
10.7.11.1. Participant’s overview
10.7.11.2. Financial performance
10.7.11.3. Product benchmarking
10.7.11.4. Strategic initiatives
10.7.12. Dechra Pharmceuticals
10.7.12.1. Participant’s overview
10.7.12.2. Financial performance
10.7.12.3. Product benchmarking
10.7.12.4. Strategic initiatives
10.7.13. VetPharma
10.7.13.1. Participant’s overview
10.7.13.2. Financial performance
10.7.13.3. Product benchmarking
10.7.13.4. Strategic initiatives
10.7.14. Vedco Inc.
10.7.14.1. Participant’s overview
10.7.14.2. Financial performance
10.7.14.3. Product benchmarking
10.7.14.4. Strategic initiatives
10.7.15. Mission Pharmacal Company
10.7.15.1. Participant’s overview
10.7.15.2. Financial performance
10.7.15.3. Product benchmarking
10.7.15.4. Strategic initiatives
10.7.16. Rayne Clinical Nutrition
10.7.16.1. Participant’s overview
10.7.16.2. Financial performance
10.7.16.3. Product benchmarking
10.7.16.4. Strategic initiatives
10.7.17. Neogen Corporation.
10.7.17.1. Participant’s overview
10.7.1.2. Financial performance
10.7.17.3. Product benchmarking
10.7.17.4. Strategic initiatives
10.7.18. Roquette Freres
10.7.18.1. Participant’s overview
10.7.18.2. Financial performance
10.7.18.3. Product benchmarking
10.7.18.4. Strategic initiatives
10.7.19. JP Farma
10.7.19.1. Participant’s overview
10.7.19.2. Financial performance
10.7.19.3. Product benchmarking
10.7.19.4. Strategic initiatives
10.7.20. Richmond Vet Pharma
10.7.20.1. Participant’s overview
10.7.20.2. Financial performance
10.7.20.3. Product benchmarking
10.7.20.4. Strategic initiatives
10.7.21. IDEXX Laboratories Inc.
10.7.21.1. Participant’s overview
10.7.21.2. Financial performance
10.7.21.3. Product benchmarking
10.7.21.4. Strategic initiatives
10.7.22. Fujifilm Holdings Corporation
10.7.22.1. Participant’s overview
10.7.22.2. Financial performance
10.7.22.3. Product benchmarking
10.7.22.4. Strategic initiatives
10.7.23. Carestream Health.
10.7.23.1. Participant’s overview
10.7.23.2. Financial performance
10.7.23.3. Product benchmarking
10.7.23.4. Strategic initiatives
10.7.24. Mindray Bio-Medical Electronics Co., Ltd.
10.7.24.1. Participant’s overview
10.7.24.2. Financial performance
10.7.24.3. Product benchmarking
10.7.24.4. Strategic initiatives
Chapter 11 Key Takeaways
List of Tables
Table 1 Country share estimation
Table 2 List of market players
Table 3 North America Veterinary Renal Diseases market, by region, 2018-2030 (USD Million)
Table 4 North America Veterinary Renal Diseases market, by Type, 2018-2030 (USD Million)
Table 5 North America Veterinary Renal Diseases market, by animal type, 2018-2030 (USD Million)
Table 6 North America Veterinary Renal Diseases market, by route of administration, 2018-2030 (USD Million)
Table 7 North America Veterinary Renal Diseases market, by indication, 2018-2030 (USD Million)
Table 8 North America Veterinary Renal Diseases market, by distribution channel, 2018-2030 (USD Million)
Table 9 US Veterinary Renal Diseases market, by Type, 2018-2030 (USD Million)
Table 10 US Veterinary Renal Diseases market, by animal type, 2018-2030 (USD Million)
Table 11 US Veterinary Renal Diseases market, by route of administration, 2018-2030 (USD Million)
Table 12 US Veterinary Renal Diseases market, by indication, 2018-2030 (USD Million)
Table 13 US Veterinary Renal Diseases market, by distribution channel, 2018-2030 (USD Million)
Table 14 Canada Veterinary Renal Diseases market, by Type, 2018-2030 (USD Million)
Table 15 Canada Veterinary Renal Diseases market, by animal type, 2018-2030 (USD Million)
Table 16 Canada Veterinary Renal Diseases market, by route of administration, 2018-2030 (USD Million)
Table 17 Canada Veterinary Renal Diseases market, by indication, 2018-2030 (USD Million)
Table 18 Canada Veterinary Renal Diseases market, by distribution channel, 2018-2030 (USD Million)
Table 19 Europe Veterinary Renal Diseases market, by region, 2017- 2030 (USD Million)
Table 20 Europe Veterinary Renal Diseases market, by Type, 2018-2030 (USD Million)
Table 21 Europe Veterinary Renal Diseases market, by animal type, 2018-2030 (USD Million)
Table 22 Europe Veterinary Renal Diseases market, by route of administration, 2018-2030 (USD Million)
Table 23 Europe Veterinary Renal Diseases market, by indication, 2018-2030 (USD Million)
Table 24 Europe Veterinary Renal Diseases market, by distribution channel, 2018-2030 (USD Million)
Table 25 UK Veterinary Renal Diseases market, by Type, 2018-2030 (USD Million)
Table 26 UK Veterinary Renal Diseases market, by animal type, 2018-2030 (USD Million)
Table 27 UK Veterinary Renal Diseases market, by route of administration, 2018-2030 (USD Million)
Table 28 UK Veterinary Renal Diseases market, by indication, 2018-2030 (USD Million)
Table 29 UK Veterinary Renal Diseases market, by distribution channel, 2018-2030 (USD Million)
Table 30 Germany Veterinary Renal Diseases market, by Type, 2018-2030 (USD Million)
Table 31 Germany Veterinary Renal Diseases market, by animal type, 2018-2030 (USD Million)
Table 32 Germany Veterinary Renal Diseases market, by route of administration, 2018-2030 (USD Million)
Table 33 Germany Veterinary Renal Diseases market, by indication, 2018-2030 (USD Million)
Table 34 Germany Veterinary Renal Diseases market, by distribution channel, 2018-2030 (USD Million)
Table 35 Italy Veterinary Renal Diseases market, by Type, 2018-2030 (USD Million)
Table 36 Italy Veterinary Renal Diseases market, by animal type, 2018-2030 (USD Million)
Table 37 Italy Veterinary Renal Diseases market, by route of administration, 2018-2030 (USD Million)
Table 38 Italy Veterinary Renal Diseases market, by indication, 2018-2030 (USD Million)
Table 39 Italy Veterinary Renal Diseases market, by distribution channel, 2018-2030 (USD Million)
Table 40 France Veterinary Renal Diseases market, by Type, 2018-2030 (USD Million)
Table 41 France Veterinary Renal Diseases market, by animal type, 2018-2030 (USD Million)
Table 42 France Veterinary Renal Diseases market, by route of administration, 2018-2030 (USD Million)
Table 43 France Veterinary Renal Diseases market, by indication, 2018-2030 (USD Million)
Table 44 France Veterinary Renal Diseases market, by distribution channel, 2018-2030 (USD Million)
Table 45 Spain Veterinary Renal Diseases market, by Type, 2018-2030 (USD Million)
Table 46 Spain Veterinary Renal Diseases market, by animal type, 2018-2030 (USD Million)
Table 47 Spain Veterinary Renal Diseases market, by route of administration, 2018-2030 (USD Million)
Table 48 Spain Veterinary Renal Diseases market, by indication, 2018-2030 (USD Million)
Table 49 Spain Veterinary Renal Diseases market, by distribution channel, 2018-2030 (USD Million)
Table 50 Denmark Veterinary Renal Diseases market, by Type, 2018-2030 (USD Million)
Table 51 Denmark Veterinary Renal Diseases market, by animal type, 2018-2030 (USD Million)
Table 52 Denmark Veterinary Renal Diseases market, by route of administration, 2018-2030 (USD Million
Table 53 Denmark Veterinary Renal Diseases market, by indication, 2018-2030 (USD Million)
Table 54 Denmark Veterinary Renal Diseases market, by distribution channel, 2018-2030 (USD Million)
Table 55 Sweden Veterinary Renal Diseases market, by Type, 2018-2030 (USD Million)
Table 56 Sweden Veterinary Renal Diseases market, by animal type, 2018-2030 (USD Million)
Table 57 Sweden Veterinary Renal Diseases market, by route of administration, 2018-2030 (USD Million)
Table 58 Sweden Veterinary Renal Diseases market, by indication, 2018-2030 (USD Million)
Table 59 Sweden Veterinary Renal Diseases market, by distribution channel, 2018-2030 (USD Million)
Table 60 Norway Veterinary Renal Diseases market, by Type, 2018-2030 (USD Million)
Table 61 Norway Veterinary Renal Diseases market, by animal type, 2018-2030 (USD Million)
Table 62 Norway Veterinary Renal Diseases market, by route of administration, 2018-2030 (USD Million)
Table 63 North America Veterinary Renal Diseases market, by indication, 2018-2030 (USD Million)
Table 64 Norway Veterinary Renal Diseases market, by distribution channel, 2018-2030 (USD Million)
Table 65 Asia-Pacific Veterinary Renal Diseases market, by region, 2018-2030 (USD Million)
Table 66 Asia-Pacific Veterinary Renal Diseases market, by Type, 2018-2030 (USD Million)
Table 67 Asia-Pacific Veterinary Renal Diseases market, by animal type, 2018-2030 (USD Million)
Table 68 Asia-Pacific Veterinary Renal Diseases market, by route of administration, 2018-2030 (USD Million)
Table 69 Asia-Pacific Veterinary Renal Diseases market, by indication, 2018-2030 (USD Million)
Table 70 Asia-Pacific Veterinary Renal Diseases market, by distribution channel, 2018-2030 (USD Million)
Table 71 Japan Veterinary Renal Diseases market, by Type, 2018-2030 (USD Million)
Table 72 Japan Veterinary Renal Diseases market, by animal type, 2018-2030 (USD Million)
Table 73 Japan Veterinary Renal Diseases market, by route of administration, 2018-2030 (USD Million)
Table 74 Japan Veterinary Renal Diseases market, by indication, 2018-2030 (USD Million)
Table 75 Japan Veterinary Renal Diseases market, by distribution channel, 2018-2030 (USD Million)
Table 76 China Veterinary Renal Diseases market, by Type, 2018-2030 (USD Million)
Table 77 China Veterinary Renal Diseases market, by animal type, 2018-2030 (USD Million)
Table 78 China Veterinary Renal Diseases market, by route of administration, 2018-2030 (USD Million)
Table 79 China Veterinary Renal Diseases market, by indication, 2018-2030 (USD Million)
Table 80 China Veterinary Renal Diseases market, by distribution channel, 2018-2030 (USD Million)
Table 81 India Veterinary Renal Diseases market, by Type, 2018-2030 (USD Million)
Table 82 India Veterinary Renal Diseases market, by animal type, 2018-2030 (USD Million)
Table 83 India Veterinary Renal Diseases market, by route of administration, 2018-2030 (USD Million)
Table 84 India Veterinary Renal Diseases market, by indication, 2018-2030 (USD Million)
Table 85 India Veterinary Renal Diseases market, by distribution channel, 2018-2030 (USD Million)
Table 86 Australia Veterinary Renal Diseases market, by Type, 2018-2030 (USD Million)
Table 87 Australia Veterinary Renal Diseases market, by animal type, 2018-2030 (USD Million)
Table 88 Australia Veterinary Renal Diseases market, by route of administration, 2018-2030 (USD Million)
Table 89 North America Veterinary Renal Diseases market, by indication, 2018-2030 (USD Million)
Table 90 Australia Veterinary Renal Diseases market, by distribution channel, 2018-2030 (USD Million)
Table 91 Thailand Veterinary Renal Diseases market, by Type, 2018-2030 (USD Million)
Table 92 Thailand Veterinary Renal Diseases market, by animal type, 2018-2030 (USD Million)
Table 93 Thailand Veterinary Renal Diseases market, by route of administration, 2018-2030 (USD Million)
Table 94 Thailand Veterinary Renal Diseases market, by indication, 2018-2030 (USD Million)
Table 95 Thailand Veterinary Renal Diseases market, by distribution channel, 2018-2030 (USD Million)
Table 96 South Korea Veterinary Renal Diseases market, by Type, 2018-2030 (USD Million)
Table 97 South Korea Veterinary Renal Diseases market, by animal type, 2018-2030 (USD Million)
Table 98 South Korea Veterinary Renal Diseases market, by route of administration, 2018-2030 (USD Million)
Table 99 South Korea Veterinary Renal Diseases market, by indication, 2018-2030 (USD Million)
Table 100 South Korea Veterinary Renal Diseases market, by distribution channel, 2018-2030 (USD Million)
Table 101 Latin America Veterinary Renal Diseases market, by region, 2018-2030 (USD Million)
Table 102 Latin America Veterinary Renal Diseases market, by Type, 2018-2030 (USD Million)
Table 103 Latin America Veterinary Renal Diseases market, by animal type, 2018-2030 (USD Million)
Table 104 Latin America Veterinary Renal Diseases market, by route of administration, 2018-2030 (USD Million)
Table 105 Latin America Veterinary Renal Diseases market, by indication, 2018-2030 (USD Million)
Table 106 Latin America Veterinary Renal Diseases market, by distribution channel, 2018-2030 (USD Million)
Table 107 Brazil Veterinary Renal Diseases market, by Type, 2018-2030 (USD Million)
Table 108 Brazil Veterinary Renal Diseases market, by animal type, 2018-2030 (USD Million)
Table 109 Brazil Veterinary Renal Diseases market, by route of administration, 2018-2030 (USD Million)
Table 110 Brazil Veterinary Renal Diseases market, by indication, 2018-2030 (USD Million)
Table 111 Brazil Veterinary Renal Diseases market, by distribution channel, 2018-2030 (USD Million)
Table 112 Mexico Veterinary Renal Diseases market, by Type, 2018-2030 (USD Million)
Table 113 Mexico Veterinary Renal Diseases market, by animal type, 2018-2030 (USD Million)
Table 114 Mexico Veterinary Renal Diseases market, by route of administration, 2018-2030 (USD Million)
Table 115 Mexico Veterinary Renal Diseases market, by indication, 2018-2030 (USD Million)
Table 116 Mexico Veterinary Renal Diseases market, by distribution channel, 2018-2030 (USD Million)
Table 117 Argentina Veterinary Renal Diseases market, by Type, 2018-2030 (USD Million)
Table 118 Argentina Veterinary Renal Diseases market, by animal type, 2018-2030 (USD Million)
Table 119 Argentina Veterinary Renal Diseases market, by route of administration, 2018-2030 (USD Million)
Table 120 Argentina Veterinary Renal Diseases market, by indication, 2018-2030 (USD Million)
Table 121 Argentina Veterinary Renal Diseases market, by distribution channel, 2018-2030 (USD Million)
Table 122 MEA Veterinary Renal Diseases market, by region, 2018-2030 (USD Million)
Table 123 MEA Veterinary Renal Diseases market, by Type, 2018-2030 (USD Million)
Table 124 MEA Veterinary Renal Diseases market, by animal type, 2018-2030 (USD Million)
Table 125 MEA Veterinary Renal Diseases market, by route of administration, 2018-2030 (USD Million)
Table 126 MEA Veterinary Renal Diseases market, by indication, 2018-2030 (USD Million)
Table 127 MEA Veterinary Renal Diseases market, by distribution channel, 2018-2030 (USD Million)
Table 128 South Africa Veterinary Renal Diseases market, by Type, 2018-2030 (USD Million)
Table 129 South Africa Veterinary Renal Diseases market, by animal type, 2018-2030 (USD Million)
Table 130 South Africa Veterinary Renal Diseases market, by route of administration, 2018-2030 (USD Million)
Table 131 South Africa Veterinary Renal Diseases market, by indication, 2018-2030 (USD Million)
Table 132 South Africa Veterinary Renal Diseases market, by distribution channel, 2018-2030 (USD Million)
Table 133 Saudi Arabia Veterinary Renal Diseases market, by Type, 2018-2030 (USD Million)
Table 134 Saudi Arabia Veterinary Renal Diseases market, by animal type, 2018-2030 (USD Million)
Table 135 Saudi Arabia Veterinary Renal Diseases market, by route of administration, 2018-2030 (USD Million)
Table 136 Saudi Arabia Veterinary Renal Diseases market, by indication, 2018-2030 (USD Million)
Table 137 Saudi Arabia Veterinary Renal Diseases market, by distribution channel, 2018-2030 (USD Million)
Table 138 UAE Veterinary Renal Diseases market, by Type, 2018-2030 (USD Million)
Table 139 UAE Veterinary Renal Diseases market, by animal type, 2018-2030 (USD Million)
Table 140 UAE Veterinary Renal Diseases market, by route of administration, 2018-2030 (USD Million)
Table 141 UAE Veterinary Renal Diseases market, by indication, 2018-2030 (USD Million)
Table 142 UAE Veterinary Renal Diseases market, by distribution channel, 2018-2030 (USD Million)
Table 143 Kuwait Veterinary Renal Diseases market, by Type, 2018-2030 (USD Million)
Table 144 Kuwait Veterinary Renal Diseases market, by animal type, 2018-2030 (USD Million)
Table 145 Kuwait Veterinary Renal Diseases market, by route of administration, 2018-2030 (USD Million)
Table 146 Kuwait Veterinary Renal Diseases market, by indication, 2018-2030 (USD Million)
Table 147 Kuwait Veterinary Renal Diseases market, by distribution channel, 2018-2030 (USD Million)
Table 148 List of secondary sources
Table 149 List of emerging companies
Table 150 Canine, Feline, Equine & Bovine population (in millions)
List of Figures
Fig. 1 Veterinary Renal Diseases market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Data analysis models
Fig. 6 Market formulation and validation
Fig. 7 Data validating & publishing
Fig. 8 Commodity flow analysis
Fig. 9 Volume-price market analysis: veterinary renal diseases services market
Fig. 10 Ancillary market analysis
Fig. 11 Market snapshot
Fig. 12 Segment snapshot
Fig. 13 Segment snapshot
Fig. 14 Competitive landscape snapshot
Fig. 15 Parent market outlook
Fig. 16 Ancillary market outlook
Fig. 17 Demographics of American pet owners, based on generation, %, 2022
Fig. 18 Demographics of American pet owners, based on generation, %, 2023
Fig. 19 veterinary renal diseases market dynamics
Fig. 20 veterinary renal diseases market: PORTER’s analysis
Fig. 21 veterinary renal diseases market: PESTEL analysis
Fig. 22 veterinary renal diseases market by Type: Key takeaways
Fig. 23 veterinary renal diseases market by Type, market share, 2023 & 2030
Fig. 24 Diagnosis market, 2018-2030 (USD Million)
Fig. 25 Treatment, 2018-2030 (USD Million)
Fig. 26 Drugs market, 2018-2030 (USD Million)
Fig. 27 veterinary renal diseases market by animal type: Key takeaways
Fig. 28 veterinary renal diseases market by animal type, market share, 2023 & 2030
Fig. 29 Canine market, 2018-2030 (USD Million)
Fig. 30 Feline market, 2018-2030 (USD Million)
Fig. 31 Bovine market, 2018-2030 (USD Million)
Fig. 32 Equine market, 2018-2030 (USD Million)
Fig. 33 Others market, 2018-2030 (USD Million)
Fig. 34 veterinary renal diseases market by route of administration: Key takeaways
Fig. 35 veterinary renal diseases market by route of administration, market share, 2023 & 2030
Fig. 36 Oral market, 2018-2030 (USD Million)
Fig. 37 Injectable market, 2018-2030 (USD Million)
Fig. 38 veterinary renal diseases market by indication: Key takeaways
Fig. 39 veterinary renal diseases market by Indication, market share, 2023 & 2030
Fig. 40 Renal Failure market, 2018-2030 (USD Million)
Fig. 41 Chronic Kidney Disease (CKD) market, 2018-2030 (USD Million)
Fig. 42 Renal Cystitis market, 2018-2030 (USD Million)
Fig. 43 Kidney Stones market, 2018-2030 (USD Million)
Fig. 44 Nephritis market, 2018-2030 (USD Million)
Fig. 45 Others market, 2018-2030 (USD Million)
Fig. 46 Veterinary Renal Diseases market by Distribution channel: Key takeaways
Fig. 47 Veterinary Renal Diseases market by distribution channel, market share, 2023 & 2030
Fig. 48 Veterinary hospitals & clinics market, 2018-2030 (USD Million)
Fig. 49 Pet Specialty Stores market, 2018-2030 (USD Million)
Fig. 50 E-commerce market, 2018-2030 (USD Million)
Fig. 51 Others market, 2018-2030 (USD Million)
Fig. 52 veterinary renal diseases market revenue, by region, 2023 & 2030 (USD Million)
Fig. 53 Regional market share analysis, 2023 & 2030
Fig. 54 Regional marketplace: key takeaways
Fig. 55 Regional marketplace: key takeaways
Fig. 56 North America: SWOT analysis
Fig. 57 North America veterinary renal diseases market estimates and forecasts, 2018-2030 (USD Million)
Fig. 58 Key country dynamics
Fig. 59 U.S. veterinary renal diseases market estimates and forecasts, 2018-2030 (USD Million)
Fig. 60 Key country dynamics
Fig. 61 Canada veterinary renal diseases market estimates and forecasts, 2018-2030 (USD Million)
Fig. 62 Europe: SWOT analysis
Fig. 63 Europe veterinary renal diseases market estimates and forecasts, 2018-2030 (USD Million)
Fig. 64 Key country dynamics
Fig. 65 Germany veterinary renal diseases market estimates and forecasts, 2018-2030 (USD Million)
Fig. 66 Key country dynamics
Fig. 67 UK veterinary renal diseases market estimates and forecasts, 2018-2030 (USD Million)
Fig. 68 Key country dynamics
Fig. 69 France veterinary renal diseases market estimates and forecasts, 2018-2030 (USD Million)
Fig. 70 Key country dynamics
Fig. 71 Spain veterinary renal diseases market estimates and forecasts, 2018-2030 (USD Million)
Fig. 72 Key country dynamics
Fig. 73 Italy veterinary renal diseases market estimates and forecasts, 2018-2030 (USD Million)
Fig. 74 Key country dynamics
Fig. 75 Denmark veterinary renal diseases market estimates and forecasts, 2018-2030 (USD Million)
Fig. 76 Fih.72 Key country dynamics
Fig. 77 Norway veterinary renal diseases market estimates and forecasts, 2018-2030 (USD Million)
Fig. 78 Key country dynamics
Fig. 79 Sweden veterinary renal diseases market estimates and forecasts, 2018-2030 (USD Million)
Fig. 80 Asia-Pacific SWOT Analysis
Fig. 81 Asia-Pacific veterinary renal diseases market, 2018-2030 (USD Million)
Fig. 82 Key country dynamics
Fig. 83 Japan veterinary renal diseases market, 2018-2030 (USD Million)
Fig. 84 Key country dynamics
Fig. 85 China veterinary renal diseases market, 2018-2030 (USD Million)
Fig. 86 Key country dynamics
Fig. 87 India veterinary renal diseases market, 2018-2030 (USD Million)
Fig. 88 Key country dynamics
Fig. 89 Australia veterinary renal diseases market, 2018-2030 (USD Million)
Fig. 90 Key country dynamics
Fig. 91 South Korea veterinary renal diseases market, 2018-2030 (USD Million)
Fig. 92 Key country dynamics
Fig. 93 Thailand veterinary renal diseases market, 2018-2030 (USD Million)
Fig. 94 Latin America SWOT analysis
Fig. 95 Latin America veterinary renal diseases market, 2018-2030 (USD Million)
Fig. 96 Key country dynamics
Fig. 97 Brazil veterinary renal diseases market, 2018-2030 (USD Million)
Fig. 98 Mexico veterinary renal diseases market, 2018-2030 (USD Million)
Fig. 99 Argentina veterinary renal diseases market estimates and forecasts, 2018-2030 (USD Million)
Fig. 100 MEA SWOT analysis
Fig. 101 MEA veterinary renal diseases market, 2018-2030 (USD Million)
Fig. 102 Key country dynamics
Fig. 103 South Africa veterinary renal diseases market, 2018-2030 (USD Million)
Fig. 104 Key country dynamics
Fig. 105 Saudi Arabia veterinary renal diseases market estimates and forecasts, 2018-2030 (USD Million)
Fig. 106 Key country dynamics
Fig. 107 UAE veterinary renal diseases market, 2018-2030 (USD Million)
Fig. 108 Key country dynamics
Fig. 109 Kuwait veterinary renal diseases market, 2018-2030 (USD Million)
Fig. 110 Market participant categorization
Fig. 111 Heat map analysis
Fig. 112 Key strategies deployed by market players

Companies Mentioned

  • Mars inc.
  • Nestle Purina Petcare
  • Hills Pet Nutrition.
  • J M Smucker.
  • General Mills
  • Zoetis Inc.
  • Merck & Co. Inc.
  • Elanco.
  • Phibro Animal Health Corporation.
  • Ceva Sante Animale
  • Boehringer Ingelheim Animal Health
  • Dechra Pharmceuticals
  • VetPharma
  • Vedco Inc.
  • Mission Pharmacal Company
  • Rayne Clinical Nutrition
  • Neogen Corporation.
  • Roquette Freres
  • JP Farma
  • Richmond Vet Pharma
  • IDEXX Laboratories Inc.
  • Fujifilm Holdings Corporation
  • Carestream Health.
  • Mindray Bio-Medical Electronics Co., Ltd.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages154
PublishedJanuary 2024
Forecast Period2023 - 2030
Estimated Market Value ( USD ) in 2023 $ 15.66 Billion
Forecasted Market Value ( USD ) by 2030 $ 22.9 Billion
Compound Annual Growth Rate5.4%
Regions CoveredGlobal
No. of Companies Mentioned24

Related Topics

Related Reports

Global Veterinary Eye Care Market Size, Share & Trends Analysis Report by Animal Type (Canine, Feline), Type, Route of Administration, Indication, Sales Channel, Region, and Segment Forecasts, 2024-2030 - Product Image

Global Veterinary Eye Care Market Size, Share & Trends Analysis Report by Animal Type (Canine, Feline), Type, Route of Administration, Indication, Sales Channel, Region, and Segment Forecasts, 2024-2030

  • Report
  • 180 Pages
  • Global
From
Veterinary Dermatology Drugs Market Size, Share & Trends Analysis Report By Indication, By Type, By Animal Type, By Route Of Administration, By Distribution Channel, By Region, And Segment Forecasts, 2023 - 2030 - Product Image

Veterinary Dermatology Drugs Market Size, Share & Trends Analysis Report By Indication, By Type, By Animal Type, By Route Of Administration, By Distribution Channel, By Region, And Segment Forecasts, 2023 - 2030

  • Report
  • 150 Pages
  • Global
From
Veterinary Diagnostics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2020 - 2029 - Product Image

Veterinary Diagnostics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2020 - 2029

  • Report
  • 117 Pages
  • Global
From
Global Veterinary Diagnostic Market by Product (Consumables, Reagents & Kits, Instruments & Devices, Software & Services), Animal Type (Companion Animals, Livestock Animals), Testing Category, Disease Type, End-Use - Forecast 2024-2030 - Product Image

Global Veterinary Diagnostic Market by Product (Consumables, Reagents & Kits, Instruments & Devices, Software & Services), Animal Type (Companion Animals, Livestock Animals), Testing Category, Disease Type, End-Use - Forecast 2024-2030

  • Report
  • 185 Pages
  • Global
From
Veterinary Diagnostic Equipment Global Market Report 2024 - Product Image

Veterinary Diagnostic Equipment Global Market Report 2024

  • Report
  • 250 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.